The “warm” data in the middle, such as your old photos, can take a few seconds to retrieve. Most data is cold, and a lot of ...

This was the stock's third consecutive day of losses.

Boston Scientific Corp. closed 4.20% short of its 52-week high of $107.17, which the company achieved on February 5th.

Boston Scientific BSX -1.50% Get Free Report has outperformed the market over the past 5 years by 8.22% on an annualized basis producing an average annual return of 25.31%. Currently, Boston ...

Boston Scientific (NYSE: BSX) is buying into the business of acquisitions. The Marlborough medical device firm has announced its second acquisition thus far in 2025. Boston Scientific Corp. has ...

Bearish flow noted in Boston Scientific (BSX) with 3,259 puts trading, or 1.6x expected. Most active are 3/28 weekly 100 puts and 4/4 weekly ...

Boston Scientific (NYSE:BSX) has agreed to acquire medical device company SoniVie for around $360M upfront payment. As a strategic investor in SoniVie, Boston Scientific currently holds an equity ...

Bullish option flow detected in Boston Scientific (BSX) with 2,458 calls trading, 1.0x expected, and implied vol increasing almost 2 points to ...

March 3, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire SoniVie Ltd., a privately held medical device company ...

Boston Scientific recently announced it entered into a definitive agreement to acquire SoniVie Ltd. According to the press release, SoniVie is ...

Boston Scientific led a $175 million investment in heart disease device developer 4C Medical Technologies. The investment, which 4C Medical disclosed Wednesday, will support an ongoing pivotal ...

Boston Scientific is diving into the field of renal denervation, with a $540 million deal for SoniVie and its ultrasound-based therapy for stubbornly high blood pressure. The acquisition sets up ...